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Nordamnacanthal and damnacanthal are two anthraquinones isolated from the roots of 
Morinda elliptica. They were found to exhibit cytotoxic activity against HT29 human 
colon adenocarcinoma cells. The cytotoxic concentrations of damnacanthal and 
nordamnacanthal that inhibited 50% growth (ICso) of HT29 were 17 J.1g1ml and 7 
).l.glml respectively. For the comparative purposes, the ICsos of several cytotoxic drugs 
against HT29 were also determined. The inhibition effect of nordamnacanthal was 
found to be comparable to etoposide (ICso = 7 �glml). cisplatin (ICso = 5 �glml) and 
doxorubicin (1Cso = 6 )lg/ml). The compound was found to be less active than 
methotrexate (MTX) (ICso < 0.05 �glml) and leunase (ICso = 2 ).1g1ml). On the other 
hand, the cytotoxic effect of damnacanthal was less active as compared to all cytotoxic 
drugs. However both compounds were found to be less toxic against non-cancerous 
fibroblast 3T3 ceJJs with the ICsos of 30 /lglml (damnacanthal) and 21 /lglm] 
(nordamnacanthal) respectively. Furthermore, damnacanthal and nordamnacanthal 
were found to induce apoptosis on HT29 cells at their ICso concentration as 
IV 
demonstrated by conventional agarose gel electrophoresis and also morphological 
alterations. DNA laddering was obtained after 12 hours of treatment by both 
compounds in a dose-independent but time-dependent fashion. Both compounds also 
caused cell death with apoptotic features such as cell shrinkage, membrane blebbing, 
nuclear fragmentation, and the presence of apoptotic bodies. In addition, caspase-3 
was found to be activated during the execution of apoptosis induced by these 
compounds. This caspase activation was inhibited by a peptide based general caspase 
inhibitor, benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-V AD-FMK). 
In conclusion, this study demonstrates the potential antitumor activites of 
damnacanthal and nordamnacanthal. 
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Nordamnacanthal dan damnacanthal merupakan dua jenis antrakuinon yang 
diasingkan daripada akar Morinda elliptica. Mereka didapati menunjukkan aktiviti 
sitotoksik ke atas jujukan sel adenokarsinoma kolon manusia, HT29. Kepekatan 
sitotoksik damnacanthal dan nordamnacanthal yang dapat merencat pertumbuhan sel 
HT29 sebanyak 50% (lCso), adalah masing-masingnya 17 �g1ml dan 7 �g1m1. Untuk 
tujuan perbandingan, ICso bagi beberapa jenis dadah sitotoksik ke atas HT29 juga 
ditentukan. Kesan perencatan nordamnacanthal didapati agak setara dibandingkan 
dengan etoposid (ICso = 7 �g1ml), sisplatin (ICso = 5 �g1ml) dan doksorubisin (ICso = 
6 J.1gfml). Sebatian tersebut didapati kurang aktif berbanding dengan methotrexate 
(MTX) (ICso < 0.05 �g1ml) dan leunase (ICso = 2 �g1ml). Sebaliknya, kesan sitotoksik 
damnacanthal adalah kurang aktif berbanding dengan kesemua dadah sitotoksik. 
Walau bagaimanapun, kedua-dua sebatian itu didapati kurang aktif ke atas jujukan sel 
fibroblas bukan-kanser, 3T3 dengan leso 30 �g!ml (damnacanthal) dan 21 �g!ml 
VI 
(nordamnacanthal). Selain daripada itu. damnacanthal dan nordamnacanthal didapati 
mengarahkan apoptosis terhadap seI HT29 pada ICso masing-masing sebagaimana 
yang ditunjukkan oleh elektroforesis gel agaros konvensyenal dan juga perubahan 
morfologi. "Penanggaan DNA" diperolehi 12 jam seIepas dirawat oleh kedua-dua jenis 
sebatian dalam bentuk "bebas dos" tetapi "bergantung kepada masa". Kedua-dua 
sebatian juga menyebabkan kematian sel dengan ciri-ciri apoptosis seperti pengecutan 
sel, "membrane blebbing", fragmentasi nukleus, dan kehadiran "jasad apoptotik". 
Selain daripada itu, "caspase-3" didapati diaktifkan semasa apoptosis diarahkan oleh 
kedua-dua jenis sebatian. Pengaktifan itu adalah sensitif terhadap perencat caspase 
" 
umum, benziloksikarbonil-Val-Ala-Asp (OMe) fluorometilketon, (Z-V AD-FMK). 
Sebagai kesimpulan, hasil pengajian ini menunjukkan potensi antikanser 
damnacanthal dan nordamnacanthal. 
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1 . 1  
CHAPTER I 
INTRODUCTION 
Throughout the histoI)' of civilization, several diseases have challenged 
human health. Leprosy was the most dreaded disease in ancient times. In Medieval 
and Renaissance Europe the scourge was the bubonic plaque or Black Death. Then 
in the 19th century, a major killer often associated with extreme suffering was the 
White Death, or tuberculosis. With the advances achieved in the 20th century in 
microbiology and pharmacology, many of the infectious diseases that formerly 
killed a large population have been overcome. However, in this century cancer 
becomes an increasing problem in developing as well as developed countries. 
Statistics have shown that one person gets cancer eveI)' 30 seconds while a person 
dies of cancer eveI)' 50 seconds. Each year cancer affects at least nine million 
people worldwide and kills five million. In Malaysia, cancer is the fifth major 
cause of death in government hospitals and the estimated cancer incidence is about 
150 per 100,000. Meanwhile, the estimated number of new cancer cases in 
Malaysia per year is around 27,000 (Malaysia's Health, 1996). 
Chemotherapy is one of the four major approaches used by physicians to 
destroy cancer cells selectively. Others included surgeI)' and radiotherapy for 
treatment of localized tumors and immunotherapy, which aim to increase patient's 
own resistance to the cancer (Joseph and Joan, 1988). 
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Since the first recorded clinical trial of a chemotherapeutic agent took place 
in 1942, the field of chemotherapy has grown tremendously. Nowadays, emphasis 
has been placed on chemotherapy as a fonn of treatment for cancer patients instead 
of the use of surgery or radiotherapy. The objective of chemotherapy is to treat 
diseases without seriously banning the patient by the use of chemicals. Several 
potential chemotherapeutic agents have been discovered serendipitously while 
others have been discovered through large-scale experimental screening. Tropical 
rain forests including the one in Malaysia stores a large chemical diversity. Some 
of these natural products can be isolated and may become chemotherapeutic 
agents. Out of 12,000 species of higher plants in Malaysia, more than 1000 species 
are said to have therapeutic properties and currently being used in the local 
traditional medicine system (Said, 1995). Goniothalamin, a secondary metabolites 
isolated from the leaves and roots of Goniothalamus spp. has been shown to 
possess a potent antitumor activity in DMBA induced rat mammary tumor and 
human breast cancer cell lines (Zauyah and Azimahtol, 1992). Study by Ali et al. 
in 1996 showed that the fruits of Cerbera manghas exhibited antitumor activity 
against HeLa cell line with cytotoxic dose at 50%, CD50 value at 1 J.1g1ml. For the 
reason, recently a few private research institutions as well as local universities have 
started the program to prospect for drugs from plants. 
Since there are more than 100 different types of cancer, screening for 
potential antitumor compounds is very important. For large scale antitumor drug 
screening, in vivo and in vitro models are used. Established human tumor cell lines 
are used in preliminary screening for potential antitumor drugs. This rational 
1.3 
approach is fairly inexpensive, rapid and capable of demonstrating high sensitivity 
(Shier, 1991). 
Once certain compounds have demonstrated cytotoxicity against tumors in 
tissue culture or in small animals, the study of their actual mechanism of action is 
also very important. Many closely related derivatives could be synthesized by 
knowing their mode of action. Some of these derivatives have been great 
improvements over the original compounds in treating many types of cancer. 
The aim of this research is to evaluate further the cytotoxic potential of two 
anthraquinone compounds, nordamnacanthal and damnacanthal on human colon 
cancer cell line, lIT 29. 
The objectives of this study are: 
i) to determine the cytotoxicity of damnacanthal and nordamnacanthal 
on human colon adenocarcinoma lIT29 cells. 
ii) to study the effects of damnacanthal and nordamnacanthal on lIT29 
cells in terms of proliferation, morphological changes and the mode 
of cell death induced by the compounds. 
iii) To identify the mode of action of damnacanthal and 
nordamnacanthal. 
2.1 
CHAPTERll 
LITERATURE REVIEW 
2.1 What is Cancer? 
Cancer or a malignant tumor is also called neoplasm in the scientific or 
medical term. Neoplasm, meaning a new growth results from an inheritable change 
in a cell (or cells) which allow them to escape from many of the normal 
homeostatic mechanisms that control proliferation. When any of the dividing cells 
undergo this type of changes they are said to be transformed. Transformation may 
be triggered in a number of ways, including exposure to chemicals, certain viruses, 
and radiation. The basis of transformation is probably a mutation (a change in the 
primary structure of DNA) but it is likely to be influenced by epigenetic events 
(shifts in gene expression) (Evans, 1991). 
2.1.1 Classification of Tumors 
Tumors are classified based on a nwnber of criteria including their 
behavior, their appearances and their origin. Basically they are two types of 
tumors, benign and malignant which differ in their behavior. Table 1 shows the 
major differences between benign and malignant cells. 
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Table 1: Major differences between benign and malignant cells 
Feature Benign Malignant 
Cytoplasm Slight basophilia Marked basophilia 
Mitotic figures Few and normal Many and abnormal 
Nucleus Predominantly normal Pleomorphic 
Nucleoli Little altered Often swollen 
Tissue structure Usually normal Dyplasticlanaplastic 
Functions Usually normal Lost or deranged 
Capsule Usually intact Often lacking 
Metastasis Never Often 
Local invasion Rare Common 
Fatalities Rare Common 
(Evans, 1991) 
2.3 
2.1.2 Characteristic Features of Tumor Cells 
A summary of some of the features possibly altered in tumor cells is 
provided in Table 2. Many of these changes reflect alterations in cell 
metabolismlbehavior without any readily obvious direction of change. Therefore it 
is difficult to define any universal tumor cell characteristic. 
2.2 Molecular Basis of Cancer 
It has been realized for many years that cancer has a genetic component and 
at the level of the cell it can be said to be a genetic disease. The genetic injury may 
be acquired in somatic cells by environmental agents or inherited in the germ-line. 
The clonal progeny of single genetically damaged progenitor cell will develop as 
tumor. Recently, the involvement of specific genes has been demonstrated at the 
molecular level. These specific genes are usually the targets of genetic damage and 
can be classified into three classes as growth-promoting proto-oncogenes, the 
growth-inhibiting tumor suppressor genes, and genes that regulate apoptosis 
(Cotran et al., 1994). 
2.2.1 Oncogenes 
The term oncogenes are used to describe any gene sequence whose 
products are associated with neoplastic transformation. Many oncogenes causing 
human cancer are mutated versions of normal cellular genes that control growth 
